Tokyo, Aug. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058898) titled 'Effects of fermented milk intake in the morning on body composition and intestinal bacteria' on Aug. 28.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Institute of Science Tokyo
Condition:
Condition - Not applicable
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate effects of fermented milk intake in the morning on body composition and intestinal bacteria
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Intake placebo in the morning for 12 weeks.
Interventions/Control_2 - Intake milk protein in the morning for 12 weeks.
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Individuals who aged 18-45.
Obtained written informed consent from the participant before participation.
Key exclusion criteria - Individuals who have high protein intake in the morning
Individuals who have milk allergies.
Individuals with diabetes, and dyslipidemia.
Individuals taking any antioxidant, anti-obesity, or antidiabetes medication and supplements
Individuals who suffered from sleep apnea
Individuals who have a habit of smoking
Individuals who are set pacemaker and metal in body (excluding dental filling).
Individuals who are engaged shift work and travel with jetlag within 2 weeks.
Individuals who have a habit of strength training
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 26 Day
Anticipated trial start date - 2025 Year 08 Month 28 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067358
Disclaimer: Curated by HT Syndication.
